Department of Medicine, McMaster University, 1280 Main Street West, Hamilton L8N 3Z5, Canada.
BMC Geriatr. 2010 Jun 10;10:38. doi: 10.1186/1471-2318-10-38.
Previous studies in long-term care (LTC) have demonstrated that warfarin management is suboptimal with preventable adverse events often occurring as a result of poor International Normalized Ratio (INR) control. To assist LTC teams with the challenge of maintaining residents on warfarin in the therapeutic range (INR of 2.0 to 3.0), we developed an electronic decision support system that was based on a validated algorithm for warfarin dosing. We evaluated the MEDeINR system in a pre-post implementation design by examining the impact on INR control, testing frequency, and experiences of staff in using the system.
For this feasibility study, we piloted the MEDeINR system in six LTC homes in Ontario, Canada. All128 residents (without a prosthetic valve) who were taking warfarin were included. Three-months of INR data prior to MEDeINR was collected via a retrospective chart audit, and three-months of INR data after implementation of MEDeINR was captured in the central computer database. The primary outcomes compared in a pre-post design were time in therapeutic range (TTR) and time in sub/supratherapeutic ranges based on all INR measures for every resident on warfarin. Secondary measures included the number of monthly INR tests/resident and survey/focus-group feedback from the LTC teams.
LTC homes in our study had TTR's that were higher than past reports prior to the intervention. Overall, the TTR increased during the MEDeINR phase (65 to 69%), but was only significantly increased for one home (62% to 71%, p < 0.05). The percentage of time in supratherapeutic decreased from 14% to 11%, p = 0.08); there was little change for the subtherapeutic range (21% to 20%, p = 0.66). Overall, the average number of INR tests/30 days decreased from 4.2 to 3.1 (p < 0.0001) per resident after implementation of MEDeINR. Feedback received from LTC clinicians and staff was that the program decreased the work-load, improved confidence in management and decisions, and was generally easy to use.
Although LTC homes in our sample had TTR's that were relatively high prior to the intervention, the MEDeINR program represented a useful tool to promote optimal TTR, decrease INR venipunctures, streamline processes, and increase nurse and physician confidence around warfarin management. We have demonstrated that MEDeINR was a practical, usable clinical information system that can be incorporated into the LTC environment.
之前在长期护理机构(LTC)中的研究表明,华法林管理并不理想,经常会因为国际标准化比值(INR)控制不佳而导致可预防的不良事件发生。为了帮助 LTC 团队应对维持居民华法林治疗范围内的挑战(INR 为 2.0 至 3.0),我们开发了一种基于华法林剂量验证算法的电子决策支持系统。我们通过检查 INR 控制、检测频率以及工作人员使用系统的经验,在实施前后的设计中评估了 MEDeINR 系统。
在这项可行性研究中,我们在加拿大安大略省的六家 LTC 机构试用了 MEDeINR 系统。所有 128 名(无人工瓣膜)正在服用华法林的居民都包括在内。通过回顾性图表审核收集了 MEDeINR 实施前三个月的 INR 数据,并在中央计算机数据库中捕获了 MEDeINR 实施后三个月的 INR 数据。在实施前后的设计中比较的主要结果是治疗范围内的时间(TTR)和基于每个服用华法林的居民所有 INR 测量值的亚治疗/治疗下范围的时间。次要措施包括每月 INR 测试/居民的数量以及来自 LTC 团队的调查/焦点小组反馈。
我们研究中的 LTC 机构的 TTR 高于干预前的以往报告。总体而言,在 MEDeINR 阶段 TTR 增加(从 65%增加到 69%),但只有一个机构的 TTR 显著增加(从 62%增加到 71%,p < 0.05)。治疗上范围的时间百分比从 14%减少到 11%(p = 0.08);治疗下范围的时间百分比变化很小(从 21%减少到 20%,p = 0.66)。总体而言,每位居民的 INR 测试/30 天的平均数量从实施 MEDeINR 前的 4.2 次减少到 3.1 次(p < 0.0001)。来自 LTC 临床医生和工作人员的反馈是,该方案减少了工作量,提高了管理和决策的信心,并且通常易于使用。
尽管我们样本中的 LTC 机构在干预前的 TTR 相对较高,但 MEDeINR 方案代表了一种有用的工具,可以促进理想的 TTR、减少 INR 静脉穿刺、简化流程,并增加护士和医生在华法林管理方面的信心。我们已经证明,MEDeINR 是一种实用、可用的临床信息系统,可以整合到 LTC 环境中。